Cannara Biotech's (LOVE.TO) notice of intention to proceed with a normal course issuer bid has been accepted by the Toronto Stock Exchange, it said Wednesday.
The NCIB will allow the company to purchase up to around 1.98 million of its shares, representing 2% of the around 98.78 million shares issued and outstanding as at July 21, it said.
The buyback will begin on Aug. 4 and end on Aug. 3, 2027, Cannara added.